Rambus Total Cost of Revenue decreased by 9.1% to $36.53M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.2%, from $32.84M to $36.53M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 19.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.88M | $18.43M | $17.74M | $22.40M | $24.81M | $26.98M | $33.38M | $31.68M | $23.60M | $24.03M | $24.12M | $23.66M | $26.83M | $28.10M | $31.52M | $32.84M | $34.77M | $36.59M | $40.21M | $36.53M |
| QoQ Change | — | +9.2% | -3.7% | +26.3% | +10.8% | +8.8% | +23.7% | -5.1% | -25.5% | +1.8% | +0.3% | -1.9% | +13.4% | +4.7% | +12.1% | +4.2% | +5.9% | +5.2% | +9.9% | -9.1% |
| YoY Change | — | — | — | — | +47.0% | +46.4% | +88.2% | +41.4% | -4.9% | -10.9% | -27.8% | -25.3% | +13.7% | +16.9% | +30.7% | +38.8% | +29.6% | +30.2% | +27.6% | +11.2% |